Mymetics Corp
Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, and malaria. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; and nationa… Read more
Mymetics Corp (MYMX) - Total Assets
Latest total assets as of September 2023: $100.00K USD
Based on the latest financial reports, Mymetics Corp (MYMX) holds total assets worth $100.00K USD as of September 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Mymetics Corp - Total Assets Trend (1998–2022)
This chart illustrates how Mymetics Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Mymetics Corp - Asset Composition Analysis
Current Asset Composition (December 2022)
Mymetics Corp's total assets of $100.00K consist of 6.6% current assets and 93.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 4.3% |
| Accounts Receivable | $62.00K | 0.9% |
| Inventory | $1.00 | 0.0% |
| Property, Plant & Equipment | $159.00K | 2.2% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $6.67 Million | 91.1% |
Asset Composition Trend (1998–2022)
This chart illustrates how Mymetics Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mymetics Corp's current assets represent 6.6% of total assets in 2022, a decrease from 100.0% in 1998.
- Cash Position: Cash and equivalents constituted 4.3% of total assets in 2022, up from 1.4% in 1998.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 91.0% of total assets, an increase from 0.0% in 1998.
- Asset Diversification: The largest asset category is goodwill at 91.1% of total assets.
Mymetics Corp Competitors by Total Assets
Key competitors of Mymetics Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Mymetics Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Mymetics Corp generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Mymetics Corp is currently not profitable relative to its asset base.
Mymetics Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.00 | 0.01 | 0.02 |
| Quick Ratio | 0.00 | 0.01 | 0.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-75.43 Million | $ -70.62 Million | $ -53.73 Million |
Mymetics Corp - Advanced Valuation Insights
This section examines the relationship between Mymetics Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -4.1% |
| Total Assets | $7.32 Million |
| Market Capitalization | $22.08 USD |
Valuation Analysis
Below Book Valuation: The market values Mymetics Corp's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Mymetics Corp's assets decreased by 4.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Mymetics Corp (1998–2022)
The table below shows the annual total assets of Mymetics Corp from 1998 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $7.32 Million | -4.07% |
| 2021-12-31 | $7.63 Million | -5.73% |
| 2020-12-31 | $8.10 Million | +5.39% |
| 2019-12-31 | $7.68 Million | -1.61% |
| 2018-12-31 | $7.81 Million | -2.91% |
| 2017-12-31 | $8.04 Million | -3.57% |
| 2016-12-31 | $8.34 Million | -28.77% |
| 2015-12-31 | $11.71 Million | +6.34% |
| 2014-12-31 | $11.01 Million | -16.08% |
| 2013-12-31 | $13.12 Million | +40.38% |
| 2012-12-31 | $9.35 Million | -1.44% |
| 2011-12-31 | $9.48 Million | -28.76% |
| 2010-12-31 | $13.31 Million | -9.80% |
| 2009-12-31 | $14.76 Million | +2089.47% |
| 2008-12-31 | $674.00K | +250.96% |
| 2007-12-31 | $192.04K | -14.08% |
| 2006-12-31 | $223.52K | +110.11% |
| 2005-12-31 | $106.38K | -14.16% |
| 2004-12-31 | $123.93K | -66.14% |
| 2003-12-31 | $366.05K | -23.33% |
| 2002-12-31 | $477.44K | -71.83% |
| 2001-12-31 | $1.69 Million | +668.99% |
| 2000-12-31 | $220.40K | -91.71% |
| 1999-12-31 | $2.66 Million | -5.00% |
| 1998-12-31 | $2.80 Million | -- |